Dr. Tiffany Holcombe Svahn, MD

Dr. Svahn practices at Concord Medical Center in Concord, California, part of John Muir Health.

Dr. Svahn's NPI, 1518920479, was assigned on April 10, 2006. Dr. Svahn graduated from Vagelos College of Physicians and Surgeons in 2000. Dr. Svahn holds California license A81256.

Dr. Svahn's primary practice is Concord Medical Center, at 2540 East St, Concord, CA 94520 in Contra Costa County. The practice phone is (925) 682-8200.

Dr. Svahn's primary practice is Concord Medical Center in Concord, California, part of John Muir Health. Dr. Svahn is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is John Muir Health. Dmand AI also links Dr. Svahn to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Svahn practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Svahn's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Svahn is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Svahn's licenses on file in 2 states: California and New York.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, lung cancer, lymphedema, lymphoma and purpura and thrombocytopenia among the conditions Dr. Svahn treats.

CMS data shows 3,067 Medicare services from Dr. Svahn across 15 procedure codes in 2024, for 631 Medicare patients. Medicare paid $158,626 for them.

CMS counts 631 Medicare patients who saw Dr. Svahn in 2024. The largest group is 65 to 74, with 280 patients. 75% of them have cancer, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Svahn's median patient age at 67, with 95% women.

In 2024, Dr. Svahn wrote 1,377 Medicare Part D claims for 366 patients. 95% of them were for generic drugs. CMS names the drug for 1,253 of them, across 12 drugs with 11 or more claims each, at $315,633 in total drug cost. In 2023, CMS named 469 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Svahn for performance year 2024, reported as part of a group. Dr. Svahn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Svahn as offering telehealth.

Dmand AI links 4 papers to Dr. Svahn, published from 2016 to 2017. The most frequent topics are Breast Neoplasms. Dr. Svahn's most frequent co-authors are Patrick I. Borgen, MD, Robert Carlson, MD and Mary L. Chen, MD.

Dmand AI links Dr. Svahn to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 317 general payments to Dr. Svahn from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $622.

Dmand AI lists 1 award for Dr. Svahn, most recently CMS Stage 1 EHR in 2014.

Dr. Svahn graduated from Vagelos College of Physicians and Surgeons in 2000. Dr. Svahn is a member of ASCO.

Dr. Svahn is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.